About the Event

In Conversation with Thomas Lönngren

2016 has been a turbulent year in the international political landscape with uncertainty around what impact Brexit and the change in US presidency will have on the global pharmaceutical and medical technology industry. BioMelbourne Network is proud to host Dr Thomas Lönngren for a conversational workshop to explore regulatory and clinical strategies for market access in the EU and US with insights into the changing global landscape.

This workshop will provide an outlook for 2017 on emerging trends and give companies the opportunity to present their case studies and questions in an intimate group setting. Limited places are available and preference will be given to companies developing strategies for global market entry. Participants can draw on Dr Lönngren’s experience as Executive Director of the European Medicines Agency, as well as his present role advising pharmaceutical companies globally on regulatory aspects and market access on drug development.

Who should attend: Biotech and Medtech CEOs, CSOs, Regulatory & Clinical Affairs Managers and Directors and anyone with an interest in regulatory and market access developments in Europe and US.

---